Abbott agrees to nearly $385 million infant formula settlement
The Justice Department announced a settlement with Abbott Laboratories over allegedly noncompliant infant formula and nutritional products purchased through government programs. Abbott denied the allegations and did not admit facts or liability.
The U.S. Department of Justice announced on September 14, 2026, that Abbott Laboratories agreed to pay approximately $385 million to resolve allegations concerning powdered infant formula and nutritional products manufactured in Sturgis, Michigan, and Casa Grande, Arizona. The alleged conduct covered January 1, 2018, through December 31, 2022, and involved purchases supported by WIC and Medicaid.
The government alleged that roof leaks and damaged spray dryers at Sturgis created contamination risks. The action, United States ex rel. Millard et al. v. Abbott Laboratories, No. 1:22-cv-994, is in the U.S. District Court for the Western District of Michigan. The False Claims Act, 31 U.S.C. §§ 3729–3733, provides the federal statutory basis for the settled reimbursement claims.
The signed agreement specifies $384,999,040.12 plus interest, including $348,700,868 for the United States. Abbott expressly denied the allegations of the government, intervening states and whistleblowers. The agreement states that it is a compromise of disputed claims and does not constitute an admission of facts or liability.
The False Claims Act has also produced pharmaceutical settlements involving alleged prescribing incentives. On January 24, 2025, DOJ announced that Pfizer agreed to pay $59,746,277 on behalf of Biohaven Pharmaceutical Holding Company Ltd. over alleged Nurtec ODT speaker-program kickbacks before its acquisition. DOJ said Pfizer terminated the programs after acquiring Biohaven. That separate settlement resolved allegations without a determination of liability.
The Abbott agreement requires the parties to file a dismissal after receipt of the specified payment. The government's covered claims would be dismissed with prejudice while preserving other claims. The agreement expressly reserves potential criminal liability and personal-injury claims.
Cite this report
The Precedent. "Abbott agrees to nearly $385 million infant formula settlement." September 21, 2026. https://theprecedent.org/article/abbott-agrees-to-nearly-385-million-infant-formula-settlement
